Hubei Jumpcan Pharmaceutical Co., Ltd.
600566
Clasificación en acciones
#4339
Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the... Hubei Jumpcan Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the full spectrum of pharmaceutical operations, encompassing research, development, production, and marketing. The company's product lines include both traditional Chinese and Western medicines, as well as daily-use chemical products incorporating traditional Chinese medicine, and health supplements rooted in Chinese medical practices. Their diverse range of Chinese and Western pharmaceuticals addresses a wide array of therapeutic areas, such as pediatric care, women's health, respiratory conditions, digestive disorders, and geriatric medicine. Additionally, their development pipeline covers treatments for detoxification, nervous system ailments, anti-infective agents, cardiovascular issues, pain relief, nutritional deficiencies, musculoskeletal problems, and blood clotting management. Beyond medicinal products, Jumpcan also manufactures oral and skin care items. The company's Chinese medicine-based health products are designed to provide benefits like fatigue reduction, anti-aging effects, antioxidant support, and immune system boosting. Headquartered in Taixing, China, the company adopted its current name, Hubei Jumpcan Pharmaceutical Co., Ltd., in March 2015, having previously operated as Hubei Hongcheng General Machinery Co., Ltd.
Precio por acción
$3.87
Capitalización bursátil
$3.57B
Cambio (1 día)
-1.64%
Cambio (1 año)
9.08%
País
CN
Comercio Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Categoría
Healthcare
Historial de rendimiento por dividendo de Hubei Jumpcan Pharmaceutical Co., Ltd. (600566)
Rendimiento por dividendo (TTM) de Hubei Jumpcan Pharmaceutical Co., Ltd. (símbolo bursátil: 600566) al 2024-12-31: 4.48%
Rendimiento promedio por dividendo de los últimos 5 años: 3.84%
Rendimiento promedio por dividendo de los últimos 5 años: 3.84%
Historial de rendimiento por dividendo de Hubei Jumpcan Pharmaceutical Co., Ltd. (600566) desde 2001 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
| Año | Rendimiento por dividendo | Cambiar |
|---|---|---|
| 2026 (TTM) | 6.73% | -15.45% |
| 2025 | 7.96% | 77.68% |
| 2024 | 4.48% | 68.42% |
| 2023 | 2.66% | 6.83% |
| 2022 | 2.49% | 56.60% |
| 2021 | 1.59% | -73.23% |
| 2020 | 5.94% | 16.70% |
| 2019 | 5.09% | 53.78% |
| 2018 | 3.31% | 73.30% |
| 2017 | 1.91% | -12.79% |
| 2016 | 2.19% | 50.00% |
| 2015 | 1.46% | 421.43% |
| 2014 | 0.28% | 115.38% |
| 2013 | 0.13% | -61.76% |
| 2012 | 0.34% | -75.54% |
| 2011 | 1.39% | 41.84% |
| 2010 | 0.98% | -32.88% |
| 2009 | 1.46% | -50.00% |
| 2008 | 2.92% | 180.77% |
| 2007 | 1.04% | -58.57% |
| 2006 | 2.51% | 9.13% |
| 2005 | 2.30% | 71.64% |
| 2004 | 1.34% | 12.61% |
| 2003 | 1.19% | -1.65% |
| 2002 | 1.21% | 365.38% |
| 2001 | 0.26% | 0.00% |
Rendimientos por dividendo (TTM) de empresas similares o competidoras
| Empresa | Rendimiento por dividendo | País |
|---|---|---|
| 1.63% |
DE
|
|
| 1.50% |
DE
|
|
| 3.18% |
JP
|
|
| 0.19% |
CH
|
|
| 0.91% |
IN
|
